Author: rb809rb

  • SIREN price prediction – After 300% rally, is a 150% price hike up next?

    SIREN price prediction – After 300% rally, is a 150% price hike up next?

    Siren [$SIREN] rallied by 17% in 24 hours and was up nearly 300% over the past week. This extraordinary performance in the short term has captured the attention of traders and investors once again.

    In the second half of March, the memecoin burst past the $0.76 resistance and briefly ascended past the $4-level. However, it has retraced this rally since then.

    Source: $SIREN/$USDT on TradingView

    The major rally and the deep retracement since then must have rocked investor confidence. Based on the 1-day chart’s price action, it can be argued that the move below the swing low at $0.225 earlier this month has shifted the structure bearishly.

    On the other hand, the volume on 4 April was the highest daily volume since 7 February. It was a statement of intent from the buyers as they rescued $SIREN’s price from falling even further below the $0.225 swing low.

    The OBV made new highs following this spike in demand, with the Stochastic RSI climbing back from the bearish extreme and heading higher. The MACD also seemed to be laboring to climb back above the zero line.

    Which way should $SIREN traders form their bias?

    The recent momentum and buying volume were a fantastic recovery from the extremely deep retracement. At the same time, the retracement in question might have been a structural shift.

    Based on the evidence at hand, the latter scenario appeared more likely. Given the market sentiment and potential for a Bitcoin [BTC] sell-off, traders should be prepared to take profits at key resistance levels.

    Source: $SIREN/$USDT on TradingView

    The triangle formation in March saw a bearish breakdown, but the consolidation around $1.88 affected the pattern’s reliability. Some analysts would see the pattern is broken and invalidated too.

    What matters is the sentiment the pattern is trying to capture. The willingness among sellers to force prices lower after increasingly shallow bounces after 23 March is the highlight.

    Now, the $0.762-level is under siege once more. A breakout beyond this level will likely see $SIREN rally to $1.88. These are the two levels that holders and traders can use to take profits.

    Final Summary

    • $SIREN has rallied by nearly 300% in a week, recovering from the drop below the $0.2255 swing low.
    • Current move would likely see a breakout to $1.88, but traders and holders should remember to take profits.
  • Cardano In Danger Zone? Trader Drops ‘Time Bomb’ Claim

    Cardano In Danger Zone? Trader Drops ‘Time Bomb’ Claim

    Cardano’s short sellers are taking a beating. Over the past 24 hours, over $500,000 worth of short positions were liquidated as $ADA hovered near $0.25 — a price point that one unnamed trader is calling a powder keg ready to blow.

    Whale Activity Signals Quiet Accumulation

    Exchange data tells a quiet story of confidence beneath the surface. More $ADA has been flowing out of exchanges than flowing in, a pattern that often shows up when large holders are pulling coins into private wallets rather than preparing to sell.

    Whale accumulation has picked up as well. Reports indicate the number of wallets holding 10 million or more $ADA recently climbed to a four-month high, even as the price continued sliding.

    The liquidation data reflects the same tension. Of the $637,500 in total $ADA positions wiped out in the past day, shorts accounted for nearly 80% of the damage. Long positions absorbed the rest — about $135,200 — as buyers got caught on the wrong side of brief downward swings.

    BREAKING:

    CARDANO ( $ADA ) IS A TICKING TIME BOMB SAYS EXPERT TRADER 🤯🤯🤯

    The target is 1.20$ end of this week.

    In his words “there’s nowhere left for it to go this week it will either go up or go down.” pic.twitter.com/Sg8yef818a

    — 🪏Mintern (@MinswapIntern) April 9, 2026

    A Chart Four Years In The Making

    The technical case for a breakout rests on a structure that has been building since early 2022. Based on a chart shared by Minswap DEX’s self-described chief meme officer Mintern on X, $ADA has been trading inside a horizontal price channel for roughly four years, bouncing between a ceiling and a floor without breaking decisively in either direction.

    $ADA’s all-time high of $3.10 came in 2021. After that peak, the coin dropped sharply. By the week of January 17, 2022, it had fallen from $1.60 to below $0.91, before eventually settling near the top of the channel around $1.18.

    That range — from roughly $0.23 on the low end to $1.18 on the high end — has contained price action ever since.

    $ADA market cap currently at $9.21 billion. Chart: TradingView

    A descending trendline developed inside the channel starting around August 2025, when $ADA peaked near $1.02 and then began forming a series of lower highs.

    Today, the price sits where that trendline meets the channel’s lower boundary — a compression point that typically forces a decisive move.

    The unnamed trader’s analysis calls for a breakout to the upside with a price target near $1.20 before the week ends. That would represent a roughly 380% gain from current levels in less than two days.

    A Bold Call From An Unknown Voice

    Still, the prediction carries real weight only if its source does — and that source remains unknown. The trader behind the “ticking time bomb” call was never identified in the analysis Mintern shared, which raises obvious questions about credibility, track record, and motive.

    A 380% rally in under 48 hours is an extraordinary claim. Extraordinary claims demand more than an anonymous chart.

    Featured image from Meta, chart from TradingView

  • Powell, Bessent Warn Banks About Security Risks From Anthropic’s Mythos AI: Bloomberg

    Powell, Bessent Warn Banks About Security Risks From Anthropic’s Mythos AI: Bloomberg

    In brief

    • U.S. officials warned major banks about cybersecurity risks tied to Anthropic’s Mythos AI model, Bloomberg reports.
    • The system can reportedly identify and exploit vulnerabilities in operating systems and browsers.
    • Anthropic has limited access to the model while it evaluates potential security risks.

    U.S. Treasury Secretary Scott Bessent and Federal Reserve Chair Jerome Powell reportedly convened a meeting with Wall Street bank CEOs earlier this week to warn about cybersecurity risks tied to a new artificial intelligence model from Anthropic.

    According to a report by Bloomberg, the meeting included executives from Citigroup, Bank of America, Wells Fargo, Morgan Stanley, and Goldman Sachs. Officials discussed Anthropic’s new AI model Mythos, which has recently drawn broad concern over its apparent advanced cybersecurity capabilities.

    Officials convened the meeting to ensure banks understand the risks posed by systems capable of identifying and exploiting software vulnerabilities across operating systems and web browsers, and to encourage institutions to strengthen defenses against potential AI-assisted cyberattacks targeting financial infrastructure.

    Security researchers have warned that tools capable of automatically discovering vulnerabilities could accelerate both defensive security work and malicious hacking if misused.

    Anthropic’s Mythos model first surfaced online in March after draft materials about the system leaked online, revealing what the company described as its most capable AI model yet. In testing, the system reportedly found thousands of previously unknown software vulnerabilities, including zero-day flaws across major operating systems and web browsers.

    Anthropic researchers said in a report earlier this week that Mythos Preview’s vulnerability-discovery capabilities were not intentionally trained, but instead emerged from broader improvements in the model’s coding, reasoning, and autonomy.

    “The same improvements that make the model substantially more effective at patching vulnerabilities also make it substantially more effective at exploiting them,” the firm wrote.

    Because of those capabilities, Anthropic has restricted access to a small group of cybersecurity organizations.

    “Given the strength of its capabilities, we’re being deliberate about how we release it,” Anthropic said in a statement. “As is standard practice across the industry, we’re working with a small group of early access customers to test the model. We consider this model a step change and the most capable we’ve built to date.”

    To address that risk, Anthropic is testing Mythos through Project Glasswing, a collaboration with major technology and cybersecurity companies that uses the model to identify and patch vulnerabilities in critical software before attackers can exploit them.

    “Project Glasswing is a starting point. No one organization can solve these cybersecurity problems alone,” the company said in a statement. “Frontier AI developers, other software companies, security researchers, open-source maintainers, and governments across the world all have essential roles to play.”

    Anthropic did not immediately respond to Decrypt’s request for comment.

    Daily Debrief Newsletter

    Start every day with the top news stories right now, plus original features, a podcast, videos and more.

  • Exodus Rolls Out ‘Exodus Pay’ to Turn Bitcoin Wallet Into Spending App

    Exodus Rolls Out ‘Exodus Pay’ to Turn Bitcoin Wallet Into Spending App

    In brief

    • Exodus launches Exodus Pay, a feature that lets users spend crypto directly from its wallet app.
    • The rollout is limited to five U.S. states, including New York and California.
    • The company says the feature aims to reduce reliance on third-party payment platforms.

    Exodus, the publicly traded crypto wallet provider, began rolling out a new “Exodus Pay” feature on Wednesday, aiming to turn its self-custodial storage app into a tool for everyday payments. The launch is currently limited to users in five states, including New York and California.

    The Omaha-based firm listed its stock on the New York Stock Exchange in 2024 and says the new feature expands the role of its wallet beyond storage into payments. The company positions the service as an alternative to centralized payment apps.

    “Most payment apps are third parties that hold your funds for you,” Exodus co-founder and CEO JP Richardson told Decrypt. “That means they can freeze your account, reverse transactions, and decide what you’re allowed to buy.” Exodus, by contrast, can’t do that, because users remain in control of their funds at all times.

    The company says Exodus Pay works within the existing wallet app and allows users to spend USD-backed stablecoins, such as USDC, or Bitcoin at merchants that accept Visa or Apple Pay.

    “The problem with self-custody until now has been the friction. Seed phrases, complicated networks—most self-custody consumer experiences aren’t built for someone who just wants to pay for groceries or send friends money,” Richardson said.

    To encourage adoption, Exodus says it will subsidize network fees and allow transfers using phone numbers. The service remains geographically limited due to regulatory requirements. It is currently available only in Nebraska, Texas, Florida, New York, and California.

    Richardson said the company has focused on simplifying the user experience, claiming that “someone with zero crypto experience should be able to use an app intuitively.”

    Exodus joins a growing list of crypto wallet developers that let customers pay for purchases using crypto or stablecoins, including Coinbase, BitPay, and PayPal.

    After the initial launch, Richardson said the company plans to expand the service nationwide over the next several weeks.

    “By mid-April, everyone in America will have Exodus Pay in their app,” Richardson said. For existing users, the feature will appear as an automatic update rather than a new download. “If you already have Exodus, you’ll have Exodus Pay,” he added.

    Daily Debrief Newsletter

    Start every day with the top news stories right now, plus original features, a podcast, videos and more.

  • US federal court hears new case against Trump tariffs

    US federal court hears new case against Trump tariffs

    The case is to overturn the temporary tariffs that Trump imposed after the Supreme Court struck down his earlier ones.

    The centrepiece of United States President Donald Trump’s economic policy — sweeping taxes on global imports — is under legal assault again.

    A three-judge panel of the US Court of International Trade, a specialised court in New York, is hearing oral arguments on Friday in an attempt to overturn the temporary tariffs Trump turned to after the Supreme Court in February struck down his preferred choice — even bigger, even more sweeping tariffs.

    Recommended Stories

    list of 4 itemsend of list

    Several US states and small businesses have said the 10 percent global import tax that Trump imposed in February sidesteps the Supreme Court ruling that invalidated most of his previous tariffs.

    A group of 24 mostly Democratic-led states and two small businesses sued the Trump administration to stop the new tariffs, which went into effect on February 24.

    Oregon’s lawyer Brian Marshall told the judges they should block the 10 percent tariffs rather than let them expire on the normal 150-day timeline, to keep Trump from invoking a variety of laws to keep them indefinitely.

    “[If] we have a successive series where there’s always tariffs in place, that’s a problem,” Marshall said.

    Marshall also said the tariffs were based on archaic authority that was meant to protect the US dollar from sudden depreciation in the 1970s, when dollars could be exchanged for gold reserves held in Fort Knox.

    He said that authority was meant to resolve significant “balance-of-payments deficits”, and Trump cannot repurpose it to address routine trade deficits.

    Tariffs, a central pillar

    Trump has made tariffs a central pillar of his foreign policy in his second term, claiming sweeping authority to issue tariffs without input from Congress.

    The administration has said that global tariffs are a legal and appropriate response to a persistent trade deficit caused by the fact that the US imports more goods than it exports.

    “President Trump is lawfully using the executive powers granted to him by Congress to address our country’s balance of payments crisis,” White House spokesperson Kush Desai said.

    Trump imposed the new tariffs under Section 122 of the Trade Act of 1974, which authorises duties of up to 15 percent for up to 150 days on imports during “large and serious United States balance-of-payments deficits” or to prevent imminent depreciation of the dollar.

    The states and small businesses argue that the Trade Act’s tariff authority is meant only to address short-term monetary emergencies, and routine trade deficits do not match the economic definition of “balance-of-payments deficits.”

    Trump announced the new tariffs on February 20, the same day the Supreme Court handed him a stinging defeat when ⁠it struck down a broad swath of tariffs he had imposed under the International Emergency Economic Powers Act (IEEPA), ruling that the law did not give him the power he claimed.

    No US president before Trump had used the IEEPA or Section 122 to impose tariffs. The two lawsuits do not challenge other Trump tariffs made under more traditional legal authority, such as recent tariffs on steel, aluminium, and copper imports.

  • Is the US-Iran ceasefire already doomed?

    Is the US-Iran ceasefire already doomed?

    Expectations for the upcoming talks between the United States and Iran in Pakistan are understandably modest. There is even a risk that the meeting won’t take place at all.

    Yet, paradoxically, the failure of the talks may still shift the situation in a positive direction. Indeed, the true measure of the ceasefire’s success may not be whether it yields a lasting accord with Iran. It may lie instead in what it forestalls: Even in the absence of a durable deal, Washington may have found a way to avoid going back into a futile war.

    Tehran’s reaction to the talks has been ambivalent. The government has cast the ceasefire as a victory, projecting strength at home and abroad. But many voices close to the security establishment are less sanguine, warning that Iran may have sacrificed momentum and weakened its deterrent posture by settling for anything short of a complete and immediate end to hostilities.

    Still, whatever the internal debate, there is little dispute about one point: The ceasefire, as it stands, reflects Iran’s terms more than America’s.

    Let us consider what the ceasefire entails. The negotiations will proceed on the basis of Tehran’s 10-point proposal, not US President Donald Trump’s 15-point plan for Iranian capitulation. As part of this, Iran will retain control of the Strait of Hormuz during the truce – continuing to collect transit fees from passing vessels.

    Washington appears to have conceded two critical points: That it tacitly acknowledges Iran’s authority over the strait, and that Tehran holds the upper hand in setting the terms of the talks. Trump himself seemed to signal as much, describing the Iranian proposal on social media as a “workable” foundation.

    Unsurprisingly, this has raised eyebrows in Washington, given the scope of Iran’s demands. They range from recognition of Iran’s continued control over the strait and acceptance of uranium enrichment, to the lifting of all US primary and secondary sanctions – as well as United Nations sanctions – to a withdrawal of US combat forces from the region, and a comprehensive ceasefire that would extend to Israel’s operations in Lebanon and Gaza.

    It is difficult to imagine Washington agreeing to such terms in full. Just as uncertain is how far Iran is willing to bend – whether it would pare back its demands or hold firm on a maximalist position.

    The geopolitical consequences would be profound if the final outcome reflects these demands. Yet it is equally important to recognise that Tehran is unlikely to wield control of the Strait of Hormuz as a blunt instrument of coercion. Rather, it is more likely to use that leverage to rebuild economic ties with Asian and European partners – countries that once traded extensively with Iran but were pushed out of its market over the past 15 years by US sanctions. Even so, this would be a bitter pill for Iran’s regional rivals.

    Trump, however, has already hinted he may be prepared to accept such an arrangement, noting that the US itself is not dependent on the oil that flows through the strait. The burden, in other words, would fall far more heavily on Asia and Europe.

    Tehran’s insistence that the ceasefire extend to Israel may prove the most difficult obstacle, given that the latter is not party to the talks and has long resisted being bound by agreements it did not help shape.

    For Iran, this demand is rooted in three considerations. First, solidarity with the peoples of Gaza and Lebanon is not merely rhetorical; it is central to Tehran’s regional posture. Having been widely perceived as abandoning these constituencies in 2024, Iran can ill afford another rupture that would further weaken the so-called “axis of resistance”.

    Second, continued Israeli bombardment risks reigniting confrontation between Israel and Iran – a cycle that has already flared twice since October 7, 2023. The linkage between these arenas is not only real but widely acknowledged, including in Western rhetoric that casts Iran as the hub of resistance to Israeli and US policies, expressed through its network of allied groups in Lebanon, Palestine, Iraq and Yemen. From Tehran’s vantage point, a durable halt to its own conflict with Israel cannot be separated from ending Israel’s wars in Gaza and Lebanon. As such, it is not an aspirational add-on but a necessary condition.

    Perhaps more consequentially, tying Israel to the ceasefire is a test of Washington’s willingness – and ability – to restrain its closest regional ally. If Trump cannot, or would not, do so, the value of any ceasefire with Washington comes into question. An agreement that leaves Israel free to reignite hostilities – and the US unable to keep itself from being drawn back in – offers little assurance of stability. Under such conditions, the utility of a ceasefire with the Trump administration diminishes sharply.

    Whatever the outcome of the talks in Islamabad, the strategic landscape has already been altered. Trump’s failed war has weakened the credibility of US military threats. Washington can still brandish force, but after a costly and futile conflict, such warnings no longer carry the same weight.

    A new reality now shapes US-Iran diplomacy: Washington can no longer dictate terms. Any agreement would require genuine compromise – patient, disciplined diplomacy that tolerates ambiguity, qualities rarely associated with Trump. It may also necessitate the involvement of other major powers, particularly China, to help stabilise the process and reduce the risk of a relapse into conflict.

    All of this argues for tempered expectations. Yet even if the talks collapse – and even if Israel resumes attacks on Iran – it does not automatically follow that the US would be drawn back into war. There is little reason to believe a second round would end differently, or that it would not again leave Iran positioned to disrupt the global economy. No wonder Tehran feels confident that its deterrence has been restored.

    The more plausible outcome is a new, non-negotiated status quo – one not codified through formal agreement but sustained by mutual constraint. The US would stay out of the war; Iran would continue to exert control over traffic through the Strait of Hormuz; Israel and Iran would continue a low-level conflict. A full-scale US-Iran war would be, for the moment, averted.

    Such an equilibrium would reflect not enough political will to reach a comprehensive settlement, but sufficient shared interest to avoid a wider conflagration – and a degree of tolerance for an arrangement in which both sides could claim partial victory.

    Iran could plausibly claim it weathered the combined might of Israel and the US while emerging with its geopolitical position intact – if not strengthened. Trump, for his part, could argue that he avoided another forever war, steadied energy markets, and secured tactical gains by degrading Iran’s military capabilities.

    So long as both sides cling to a narrative of victory, a fragile equilibrium – absent full-scale war – may yet endure.

    The views expressed in this article are the author’s own and do not necessarily reflect Al Jazeera’s editorial stance.

  • ‘Ride Along 3’ With Ice Cube, Kevin Hart Hires New Writer After a Decade in Development

    ‘Ride Along 3’ With Ice Cube, Kevin Hart Hires New Writer After a Decade in Development

    Turns out, there’s more story to tell!

    Ice Cube and Kevin Hart may dust off their bickering buddy act now that “Ride Along 3” is once again in early development at Universal. Tim Story, the director of the two previous installments in the cop comedy franchise, and Will Packer, the producer, are also likely back for more. Before you reserve your ticket, it’s worth noting that all of these players have been trying to get another “Ride Along” off the ground for nearly a decade without success.

    That could change. The big news, which Variety has confirmed, is that Daniel Gold, the writer of the Netflix/CBC comedy series “Workin’ Moms,” has been hired to write the screenplay.

    It makes sense that Universal, the studio behind the “Ride Along” films, would want to revive the series. “Ride Along” grossed $155 million when it debuted in 2014, while “Ride Along 2” earned $125 million when it hit theaters in 2016. So what’s behind the delay? The answer may be that big screen comedies have fallen out of favor in recent years. Major studios have largely ceded that ground to streamers like Netflix and Prime Video, which have invested more heavily in the genre.

    For those who may be hazy on the plot of the “Ride Along” films, they follow a security guard who is desperate to prove himself to his girlfriend’s police officer big brother.

    Story and Hart are about to reunite on the upcoming Netflix comedy “72 Hours.” Packer produced “You, Me & Tuscany,” a rom-com with  Halle Bailey and Regé-Jean Page that Universal premiered this weekend. And Cube recently starred in “War of the Worlds” and played himself in last winter’s “Anaconda” reboot.

  • Natasha Lyonne Claims ‘I Was Detained’ by ICE After Being Removed From Flight Following the ‘Euphoria’ Premiere

    Natasha Lyonne Claims ‘I Was Detained’ by ICE After Being Removed From Flight Following the ‘Euphoria’ Premiere

    Natasha Lyonne claimed in a new X post that she was “detained” by ICE after she was kicked off a flight following her April 7 appearance at the “Euphoria” Season 3 premiere in Hollywood. The Emmy nominee, whose appearance on the “Euphoria” red carpet went viral due to her see-through top, was clarifying widely-circulated reports report that claimed she was kicked off a flight from Los Angeles to New York before it took off due to unruly behavior. Page Six was first to report the story.

    “Indeed, I took a Lunesta once seated, to ensure some shut eye on the Delta One red eye flight to NYC,” Lyonne posted on X in response to one of the reports tweeted by E! News. “Boarded seamlessly with just a backpack and sneakers, eager for a nap. Plan was to be bushy tailed & beauty rested, as I was meant to head straight to glam for a slot with our beloved Drew Barrymore upon landing. Was looking forward to seeing Drew & an in depth convo, but I guess ICE had other plans & I was detained instead. Sign of the times, I guess. Thanks for all the love and support. Never had a problem with Delta or TSA before. Heart is with our unpaid TSA workers. Apologies to any travelers who were delayed.”

    Variety has reached out to Lyonne’s agents, plus representatives for ICE and the Department of Homeland Security, for comment.

    Lyonne first revealed she was heading to New York City to appear on “The Drew Barrymore Show” in an April 9 post on X in which she called out the Page Six report by writing: “My heart is with all the unpaid TSA agents at our airports. Sure was looking forward to speaking honestly with Drew Barrymore yesterday but guess wasn’t in the cards. Who owns page six/New York Post now again?”

    Hours after posting, Lyonne popped up in New York City and walked the red carpet at the premiere for the Focus Features documentary “Lorne.” She also attended the film’s after party, where she took photos with friends such as Seth Meyers and Sarah Sherman. Lyonne walked the red carpet with friend Hamer Morgenstern.

    Lyonne revealed in January on X that she had relapsed and was no longer sober, but she circled back with fans in March to announce she was “doing a whole lot better and back on her feet.”

  • Some IBS Treatments May Be Linked to Slightly Higher Risk of Early Death

    Some IBS Treatments May Be Linked to Slightly Higher Risk of Early Death

    Female examines food in refridgeratorShare on Pinterest
    A new study linked certain medications that treat irritable bowel syndrome to a higher risk of early death, but the overall risk is low. Laura Herrera/Stocksy
    • Researchers say some medications prescribed for irritable bowel syndrome (IBS) may increase a person’s risk of early death.
    • However, experts say that risk is relatively small and the benefits of using medication to ease the discomfort of IBS outweighs these concerns.
    • They add that people with IBS can also manage symptoms by adhering to a diet that minimizes trigger foods, as well as exercising daily and managing stress.

    Some medications commonly prescribed to treat symptoms of irritable bowel syndrome (IBS) may increase the long-term risk of early death, a new study reports.

    Scientists from Cedars-Sinai Health Sciences University in Los Angeles say that long-term use of two of the medications — loperamide and diphenoxylate — is associated with approximately double the risk of death.

    They added that long-term use of antidepressants to treat IBS symptoms was associated with a 35% higher risk of death.

    However, the researchers noted that although the overall increase in risk is statistically significant, the risk to any individual is small.

    “IBS patients should not panic, but they do need to understand and weigh the small but meaningful risks when considering long-term treatments,” said Ali Rezaie, MD, the medical director of the GI Motility Program at Cedars-Sinai and senior author of the study, in a statement.

    “Many patients are diagnosed with IBS at a young age and may remain on medications for years,” Rezaie said. “However, most clinical trials of these medications last less than a year, so we know very little about their long-term safety. This study begins to address that gap.”

    Rudolph Bedford, MD, a gastroenterologist at Providence Saint John’s Health Center in Santa Monica, CA, said that the research only establishes an association between IBS medications and risk of death and not a direct cause-and-effect relationship. Bedford wasn’t involved in the study.

    “The risk to any one person is small, so there is no reason to panic,” he told Healthline.

    Bedford added that the symptoms of IBS can be painful and even debilitating, so in many cases, the medications do far more good than harm. “It’s about quality of life at the end of the day,” he said. “The benefits definitely outweigh the risks for many patients.”

    The Cedars-Sinai researchers reached their conclusions after examining two decades of health records from nearly 670,000 adults in the United States.

    They said their research is the largest real-world study to examine the long-term safety of IBS treatments.

    Researchers looked at study participants who were taking IBS medications approved by the Food and Drug Administration (FDA), as well as antidepressants, antispasmodics, and opioid-based antidiarrheal drugs such as loperamide and diphenoxylate.

    They acknowledged their study did not establish that these medications directly cause death. Instead, they said the observed associations may reflect higher rates of adverse outcomes, such as cardiovascular events, falls, and stroke.

    They added that some medications, including antispasmodics and treatments for constipation, were not found to have an association with an increased risk of all-cause mortality.

    Ketan Thanki, MD, a colorectal surgeon specializing in benign and malignant disease of the colon, rectum, and anus at the MemorialCare Todd Cancer Institute at Long Beach Medical Center, said further research is needed before any specific conclusions can be drawn. Thanki wasn’t involved in the study.

    “For now, we should still approach these findings with caution,” he told Healthline. “As the authors point out, correlation does not imply causation, and further examination of the data and additional studies are needed to determine whether other factors are also involved.”

    Nonetheless, Thanki said people with IBS should be aware of these findings.

    “People who take IBS medications should certainly not panic,” he said. “However, they should ask their physicians if they have other risk factors, which may also correlate to negative outcomes when taking the particular drugs they are on.”

    Bedford agreed with this assessment. “Patients and medical professionals need to be educated and be cognizant of the potential long-term effects. They shouldn’t have a cavalier attitude about it,” he said.

    It’s estimated that 25–45 million people in the United States have IBS.

    Of those, about 31% report having mild IBS symptoms, while 48% say they have moderate symptoms, and 20% state they have severe symptoms that can affect daily life.

    The cause of IBS isn’t known, but it is associated with a number of factors. These include:

    Common symptoms of IBS include:

    There are a number of treatments for IBS symptoms. They include:

    Acupuncture has been tested as a potential treatment for IBS, but the results so far have been mixed.

    IBS was once thought to be a condition that mostly affected younger people, but medical experts now say it can also affect older adults.

    Experts say there are pharmaceuticals as well as lifestyle habits that can help manage IBS symptoms.

    Bedford said medications can help in several ways. Among them:

    • pain reduction
    • lessening of cramps
    • decreasing diarrhea
    • loosening constipation

    “Medications are all about treating symptoms,” he said.

    Bedford said there are also several ways a person can improve symptoms through lifestyle changes. They include:

    Thanki said diet is one of the most important aspects of any treatment routine.

    “Start with dietary modification — low-FODMAP trial with dietitian guidance, add fiber, reduce fats, eat smaller portions, limit caffeine and alcohol, and avoid personal trigger foods. This is one of the most effective ways to manage IBS,” he said.

    “Add regular exercise and address sleep,” Thanki continued. “Assess for psychological comorbidities and consider gut-directed therapy such as hypnotherapy or cognitive behavioral therapy (CBT) and stress management. Lastly, an underutilized tool is addressing pelvic floor dysfunction with physical therapy and biofeedback.“

  • Estonia is the rare EU country opposing child social media bans

    As child social media bans spread across Europe and beyond, Estonia isn’t having it. On Friday, the country’s education minister said the bans won’t “actually solve problems,” while warning that the kids will find a way regardless.

    Although companies like Meta would love for you to believe it’s a fairy tale, social media addiction is associated with tangible negative repercussions for children. Studies show that its harms range from depression and anxiety to sleep deprivation and obesity. (The latter is from all the targeted junk food advertising.) On the other hand, teens can find community and support from social media.

    A growing list of countries looked at the negative data and concluded that the answer was to ban social media altogether for children. Although the age cutoff varies, legislation has been floated or enacted in Australia, Greece, France, Austria, Spain, Indonesia, Malaysia, the UK and Denmark — just to name a few.

    Estonia’s education minister believes these countries are coming at the very real problem from the wrong angle. “The way to approach this, to me, is not to make kids responsible for that harm and start self-regulating,” Kristina Kallas said at a Politico forum in Barcelona. She added that “kids will find very quickly the ways to go around and to still use social media.”

    Instead, she said the responsibility lies with governments and corporations. “Europe pretends to be weak when it comes to big American and international corporations,” she added. But she called that a “pretense,” challenging the EU to “actually take this power and start regulating the big American corporations.”

    To be fair, the EU regulates the tech industry more effectively than anywhere else in the world. But the point on childhood social bans stands.

    Another argument against the bans is that it’s a short path from the well-meaning to a more sinister erosion of basic freedoms. In February, France suggested that the next logical step after passing an under-15 social media ban would be to go after VPNs. After all, once you pass the ban, you need to enforce it — and that can mean snuffing out the tools children could use to work around it.